Journal of the National Cancer Institute
Goserelin improves long-term survival in premenopausal women with early breast cancer
Published in Women's Health Weekly, March 12th, 2009
Systematic reviews have shown that lutenizing hormone-releasing hormone agonists, including goserelin, reduce the risk of disease recurrence and death due to breast cancer in premenopausal women. However the long-term impact of goserelin was not known, particularly in comparison to women who did or did not take tamoxifen.
Women with breast cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- American Associates, Ben-Gurion University of the Negev
Female genital mutilation among Israel's Negev Bedouins has virtually disappeared -- BGU study - BioMed Central
Incidence rates of cervical cancer linked to deprivation - Children's Hospital Boston
Metastasis-promoting protein identified; could provide a prognostic test or target for breast cancer - Harvard School of Public Health
Diets that reduce calories lead to weight loss, regardless of carbohydrate, protein or fat content - JAMA and Archives Journals
Women with diabetes before or during pregnancy at higher risk of depression - Journal of the National Cancer Institute
Smoking behavior partially explains socioeconomic inequities in lung cancer incidence - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
